Evidence map›Paper›PMID 42877706›Full record

ArticleiScience2026

Promiscuous fungal peroxygenase from

David M Upp, Ivan Mateljak, Daniel Mendez-Sanchez, Patricia Gomez de Santos, Israel Sanchez-Moreno, Morgane Valles, Katarzyna Świderek, Vicent Moliner, Katrin Scheibner, Martin Hofrichter and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David M UppDepartment of Biocatalysis, Institute of Catalysis, CSIC, 28049 Madrid, Spain.
Ivan MateljakEvoEnzyme S.L., C/ Faraday 7, Parque Científico de Madrid, 28049 Madrid, Spain.
Daniel Mendez-SanchezDepartment of Biocatalysis, Institute of Catalysis, CSIC, 28049 Madrid, Spain.
Patricia Gomez de SantosEvoEnzyme S.L., C/ Faraday 7, Parque Científico de Madrid, 28049 Madrid, Spain.
Israel Sanchez-MorenoDepartment of Bio-organic Chemistry, Instituto de Química Orgánica General (IQOG), CSIC, C/ Juan de la Cierva, 3, 28006 Madrid, Spain.
Morgane VallesEvoEnzyme S.L., C/ Faraday 7, Parque Científico de Madrid, 28049 Madrid, Spain.
Katarzyna ŚwiderekBioComp Group, Institute of Advanced Materials (INAM), Universitat Jaume I, 12071 Castellon, Spain.
Vicent MolinerBioComp Group, Institute of Advanced Materials (INAM), Universitat Jaume I, 12071 Castellon, Spain.
Katrin ScheibnerJenaBios GmbH, Löbstedter Str. 80, 07749 Jena, Germany.
Martin HofrichterDepartment of Bio- and Environmental Sciences TU Dresden, International Institute Zittau, Markt 23, 02763 Zittau, Germany.
David Gonzalez-PerezDepartment of Biocatalysis, Institute of Catalysis, CSIC, 28049 Madrid, Spain.
Miguel AlcaldeDepartment of Biocatalysis, Institute of Catalysis, CSIC, 28049 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal unspecific peroxygenases (UPOs) are appealing enzymes for C-H oxyfunctionalization reactions, and, among them, the short UPO type from

Indexed as

antiChaetomium globosumdirected evolutioninverted enantioselectivityisophorone-Markovnikov oxidationperoxygenaseterpenesyeast

Identifiers

PMID42877706
PMCPMC13663891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.